Kumar R, Fischer A B, Lee S K. "一种卡匹色替杂质29的合成方法" [P]. US Patent, US 10232182 B2, 2015-05-02.
Rossi M, Nielsen H, Nowak P. "Method for the Synthesis of Capivasertib Impurity 29" [P]. European Patent, EP 3742037 A1, 2025-07-16.
发明人何建平,高志强,孙丽萍. "A Process for Preparing High-Purity Capivasertib Impurity 29" [P]. 中国发明专利, 专利号 CN 110504756 B, 授权公告日 2024-11-22.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 卡匹色替杂质29 in Pharmaceutical Formulations". J. Agric. Food Chem., 2024, 600, (4), 8047-8061.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 卡匹色替杂质29 as an Impurity". Rapid Commun. Mass Spectrom., 2011, 831, 4912-4918.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Capivasertib Impurity 29 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2020, 2017, (7), 7374-7399.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 卡匹色替杂质29 Profile in Drug Substances According to ICH Guidelines". Molecules, 2014, 814, 873-891.